http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1397128-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-12
filingDate 2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16103c3e5f9762d79c3309cb09714c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d3ed572eba9e3007a6eaa4c27cff9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e71f0bc4f20fd2751f3547dc8efac69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b676917a9402600909892d7dbd9e6eab
publicationDate 2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1397128-A1
titleOfInvention Kappa opiate agonists for the treatment of bladder diseases
abstract Use of asimadoline (N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2,-diphenyl- acetamide) (I) or its salts, for treating diseases of the bladder. ACTIVITY : Uropathic; Analgesic. Bladder irritation was induced in rats by intraperitoneal injection of 100 ml/kg of physiological saline ( J. Pharmacol. Exp. Ther., 79 (1943) 97). The animals were treated with (I), the bladders were emptied by abdominal massage, then urine was collected over the next 6 hours. (I) Doubled the amount of urine excreted. MECHANISM OF ACTION : Kappa opiate receptor agonist.
priorityDate 2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226519353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67241745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227028206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228154676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227028205

Total number of triples: 32.